Cypherpunk Technologies Inc. reports developments tied to its privacy technology strategy, including a digital asset treasury anchored by Zcash (ZEC), investments in privacy-focused technology, and updates on Zcash-related holdings and network exposure. The company was formerly Leap Therapeutics and now combines its ZEC treasury activity with participation in the broader privacy technology ecosystem.
Company news also covers financial results, governance and advisor appointments, and the continuing biopharma work of its Leap Therapeutics subsidiary. That subsidiary is developing cancer therapy candidates including sirexatamab (DKN-01), a monoclonal antibody targeting DKK1, and the preclinical antibody program FL-501 for cachexia-related indications.
Cypherpunk Technologies (Nasdaq: CYPH) named Josh Swihart, CEO of Electric Coin Company, as a Strategic Advisor on Dec 19, 2025 to guide Zcash ecosystem and protocol-level strategy. The appointment follows a November rebrand and a $58.88 million private placement led by Winklevoss Capital.
As of Nov 17, 2025 Cypherpunk deployed approximately $68 million to acquire 233,644.56 ZEC (about 1.43% of Zcash supply) and added advisors including Zcash founder Zooko Wilcox.
Cypherpunk Technologies (Nasdaq: CYPH) announced on December 9, 2025 that Zooko Wilcox, founder of Zcash and current Chief Product Officer of Shielded Labs, has joined as a Strategic Advisor.
Zooko will advise on privacy-preserving protocols, self-sovereign digital systems, and Cypherpunk's growing Zcash treasury, supporting the company's mission to advance privacy and economic freedom. Management highlights the appointment as part of a broader effort to assemble cryptographers and technologists to support Zcash and the global privacy ecosystem.
Cypherpunk Technologies (Nasdaq: CYPH) purchased an additional 29,869.29 ZEC for $18 million at an average price of $602.63 per ZEC, raising total holdings to 233,644.56 ZEC at an average cost of $291.04. The combined position represents 1.43% of the Zcash network. The company also announced two board additions: Khing Oei and Will McEvoy, who will serve as Chief Investment Officer. Cypherpunk described Zcash as a privacy-focused digital asset and strategic hedge versus transparent networks.
Cypherpunk Technologies (Nasdaq: CYPH) announced a rebrand from Leap Therapeutics and unveiled a digital-asset treasury strategy focused on accumulating Zcash (ZEC). The company used $50 million of proceeds from a completed $58.88 million private placement to acquire 203,775.27 ZEC at an average price of $245.37 per ZEC. Winklevoss Capital led the private placement and was the only institutional investor, contributing a majority of the raise. The company will change its ticker to CYPH and begin trading under the new name on November 13, 2025. Khing Oei was appointed Chairman and Will McEvoy was named Chief Investment Officer and board member, effective November 11, 2025.
The announcement positions Cypherpunk to hold Zcash as a digital-privacy treasury asset and to pursue long-term shareholder value through active participation in Zcash.